Sp484

PANEL DISCUSSION

Date
May 19, 2024

Presenters

Speaker Image for Maria Abreu
Cedars-Sinai Medical Center
Speaker Image for Mariam Naveed
AdventHealth Medical Group at Altamonte Springs
Speaker Image for Swati Patel
University of Colorado, Rocky Mountain Regional VA
Speaker Image for Jason Samarasena
University of California, Irvine

Tracks

Related Products

Thumbnail for Early-onset GI cancers: Risk Factors, Screening and Disparities
Early-onset GI cancers: Risk Factors, Screening and Disparities
MODELING THE TUMOR MICROENVIRONMENT OF EARLY AND LATE ONSET COLORECTAL CANCER USING PATIENT-DERIVED ORGANOIDS
Thumbnail for INTERVALS OF A PLANT-BASED, LOW-CALORIE DIET IMPROVE CLINICAL SYMPTOMS COMPARED WITH USUAL DIET IN PATIENTS INITIATING ADVANCED THERAPIES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
INTERVALS OF A PLANT-BASED, LOW-CALORIE DIET IMPROVE CLINICAL SYMPTOMS COMPARED WITH USUAL DIET IN PATIENTS INITIATING ADVANCED THERAPIES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
Introduction: Diet plays an important role in ulcerative colitis (UC) yet there are no studies examining the role of diet as adjunctive therapy to medication…
Thumbnail for LYNCH SYNDROME (LS) PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) HAVE SIGNIFICANTLY HIGHER INTESTINAL NEOPLASIA RISK THAN LS PATIENTS WITHOUT IBD
LYNCH SYNDROME (LS) PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) HAVE SIGNIFICANTLY HIGHER INTESTINAL NEOPLASIA RISK THAN LS PATIENTS WITHOUT IBD
Background & Aims: Inflammatory bowel disease (IBD) and Lynch syndrome (LS) are both risk factors for colorectal cancer (CRC), however it is unclear if those with LS+IBD have compounded cancer risk or if they would benefit from more intensive surveillance…